AAT combats infections in at-risk patients
BEER-SHEVA, Israel (Press Release) – Ben-Gurion University of the Negev (BGU) researchers have discovered that alpha1-antitrypsin (AAT) could prevent deadly infections in immune system-compromised patients. Their study, reported in the Journal of Infectious Diseases by Dr. Eli C. Lewis and his team of BGU researchers, examined the effectiveness of AAT treatment in halting bacterial colonization and spread. […]
AAT combats infections in at-risk patients Read More »
Middle East, Science, Medicine, & Education
